Kaisa Health Group Holdings Ltd. reported its interim results for the six months ended 30 June 2025. The group recorded total revenue of HK$69.6 million, compared to HK$88.5 million for the same period in 2024. The dental business segment contributed HK$66.4 million in revenue, down from HK$85.9 million a year earlier, while the health care business segment generated HK$3.1 million, compared to HK$2.6 million for the prior period. The group reported a net loss of HK$9.3 million for the period, narrowing from a net loss of HK$24.3 million for the same period last year. Loss before income tax was HK$9.3 million, compared to HK$22.6 million in the prior year. Segment results for the dental business showed a segment loss before depreciation and amortisation of HK$12.0 million, compared to a segment profit before depreciation and amortisation of HK$1.9 million in the previous period. The health care business reported a segment profit before depreciation and amortisation of HK$2.5 million, up from HK$1.6 million. The total comprehensive income for the period was HK$4.4 million, compared to a total comprehensive expense of HK$34.2 million in the previous period, reflecting exchange differences arising on translation of foreign operations. No significant updates about business or operations were disclosed in the interim report.